Find public sector tenders

NULL

NULL

Meningitis B vaccine supply (2026). Estimated Total Value withheld due to commercial sensitivity (s.94(1)(b)). Publication of this information would be likely to prejudice of commercial interests of the incumbent supplier.

Pneumococcal conjugate vaccine for children (2026). Estimated Total Value withheld due to commercial sensitivity (s.94(1)(b)). Publication of this information would be likely to prejudice of commercial interests of the incumbent supplier.

BCG (tuberculosis) vaccine supply (2027). Estimated Total Value withheld due to commercial sensitivity (s.94(1)(b)). Publication of this information would be likely to prejudice of commercial interests of the incumbent supplier.

Herpes zoster vaccine, inactivated (2027). Estimated Total Value withheld due to commercial sensitivity (s.94(1)(b)). Publication of this information would be likely to prejudice of commercial interests of the incumbent supplier.

Meningococcal ACWY vaccine supply (2027). Estimated Total Value withheld due to commercial sensitivity (s.94(1)(b)). Publication of this information would be likely to prejudice of commercial interests of the incumbent supplier.

The provision of Measles, Mumps, Rubella and Varicella (MMRV) vaccine to be used as part of the national immunisation programme

The UK Health Security Agency (UKHSA) wishes to establish a contract with a supplier for the provision of a central supply of Rabies vaccine (pre and post exposure), commencing from 1 February 2026 for the UK.

The Department of Health and Social Care is seeking sponsors to deliver a high-level 2-day UK-Africa workshop in October/November 2025. This event aims to position the UK as a trusted partner in Africa’s expanding health industries and advance comm ....